Brean Capital's Top Ideas For 2015
TipRanks - at Seeking Alpha - Thu Dec 25, 6:22AM CST
By Carly Forster After an eventful 2014, the Brean Capital team came together to pick 28 stocks within each of the firm's four coverage verticals, Consumer, Healthcare, Natural Resources, and Technology, to pay attention to in 2015. Below are four...
URBN: 34.15 (-0.53), STX: 68.82 (+0.17), AWK: 53.76 (+0.59), RMTI: 8.41 (-0.07)
Cramer's Mad Money - 13 Things To Watch In The Week Ahead (12/12/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Sun Dec 14, 5:42AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Friday December 12. 13 Things to Watch in the Week Ahead: Honeywell (NYSE: HON ), Verifone (NYSE: PAY ), Darden (NYSE: DRI ), 3M (NYSE: MMM ), FedEX (NYSE: FDX ),...
JOY: 48.23 (+0.31), FDX: 176.42 (-0.52), MMM: 166.96 (+0.09), LBRDA: 50.88 (-0.37), NKE: 96.29 (+0.32), HON: 101.96 (-0.02), BBRY: 10.67 (-0.13), CHTR: 167.46 (-0.31), XON: 26.19 (+0.67), RMTI: 8.41 (-0.07), ORCL: 46.23 (+0.22), DRI: 58.42 (-0.09), KMX: 67.61 (-0.15), PAYX: 47.06 (-0.31), ISIS: 59.49 (+1.88), RHT: 70.92 (+0.47), JDSU: 14.01 (+0.13), AGIO: 109.67 (+2.45), FL: 55.31 (+0.09), PAY: 37.55 (-0.83), REGN: 400.12 (+6.07), PII: 150.40 (+0.38)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Dec 12, 7:38PM CST
Cramer will be watching company earnings while keeping an eye on oil futures to get a sense of where the market will move.
MMM: 166.96 (+0.09), SWX: 61.24 (+0.67), HON: 101.96 (-0.02), NKE: 96.29 (+0.32), CHTR: 167.46 (-0.31), BBRY: 10.67 (-0.13), XON: 26.19 (+0.67), RMTI: 8.41 (-0.07), KMX: 67.61 (-0.15), MEMP: 14.46 (-0.31), ACAD: 30.95 (+0.78), PAYX: 47.06 (-0.31), AGU: 95.91 (+0.20), TRUE: 23.50 (+0.31), LOW: 67.51 (-0.43), TWTR: 37.61 (+0.04), REGN: 400.12 (+6.07), JOY: 48.23 (+0.31), FDX: 176.42 (-0.52), LBRDA: 50.88 (-0.37), FINL: 22.79 (+0.17), ORCL: 46.23 (+0.22), DRI: 58.42 (-0.09), BAX: 74.45 (-0.04), RHT: 70.92 (+0.47), AGIO: 109.67 (+2.45), PAY: 37.55 (-0.83), PG: 93.14 (-0.15)
Dialysis Products and Services Market Report - Global Industry Analysis 2014-2020
M2 - Thu Nov 27, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/55wbqr/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. This report studies the global market for dialysis products and services from three major perspectives: product type, service type and geography. The stakeholders of this study include existing companies manufacturing dialysis products or providing dialysis services to the patients and new entrants who are planning to invest in this market. The report comprises of an executive summary section that provides a snapshot of the market with succinct information about market size and growth of different product segments, services, market share and geographic analysis of the global dialysis products and services market. The market overview section illustrates about the global market dynamics and trends comprising of drivers, restraints and opportunities that influence the current and future status of the dialysis products and services market. Several other factors such as market share analysis by major market players and Porter's five force analysis are also included in this report providing a thorough analysis about the competitive scenario in the global dialysis products and services market. Further, the market overview section also includes regulatory scenario of dialysis products and services market at global scale along with the announcements and guidelines by important bodies such as Food and Drug Administration (FDA) and Association for the Advancement of Medical Instrumentation (AAMI). These factors are explained thoroughly to help the market players in planning their strategies which will help them in expanding their presence and in strengthening their position in the global market. Report Scope Dialysis Products and Services Market, by Product type: - Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) - Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/55...s_products
NXTM: 18.39 (+0.33), BAX: 74.45 (-0.04), RMTI: 8.41 (-0.07), CMN: 42.07 (+0.40)
Rockwell closes stock offering
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 12:48PM CST
RMTI: 8.41 (-0.07)
Rockwell Medical Closes $58.5 Million Public Offering of Common Stock
GlobeNewswire - Tue Nov 25, 12:26PM CST
Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis, announced today the closing of the sale of 6,500,000 shares at $9.00 per share in an underwritten public offering for an aggregate offering amount of $58.5 million. The net proceeds from the offering, after commissions and other estimated offering expenses, were approximately $54.7 million. Rockwell has also granted the underwriters a 30-day option to purchase up to an additional 975,000 shares of common stock offered in the public offering.
RMTI: 8.41 (-0.07)
Post Earnings Update: Rockwell Medical Technologies Has Sunk 17.3% Lower in Past 2 Weeks (RMTI)
Comtex SmarTrend(R) - Mon Nov 24, 9:00AM CST
When Rockwell Medical Technologies (NASDAQ:RMTI) reported earnings two weeks ago on November 10th, 2014, analysts, on average, expected the company to report a loss of $0.10 on sales of $13.6 million. The company actually reported a loss of $0.10 per share on sales of $13.7 million, missing EPS estimates by $0.00 and matching revenue estimates. Since the company's report, shares of Rockwell Medical Technologies have fallen from $10.90 to $9.01, representing a loss of 17.3% in the past 14 days.
RMTI: 8.41 (-0.07)
NxStage Medical Unveils Streamline Express Dialyzer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 5:30PM CST
Medical device company, NxStage Medical Inc. (NXTM), recently launched Streamline Express, a gamma sterilized dialyzer for the in-center hemodialysis market.
NXTM: 18.39 (+0.33), BAX: 74.45 (-0.04), FMS: 37.40 (+0.15), RMTI: 8.41 (-0.07)
3 Healthcare Stocks Short-Sellers Are Wrong About
Motley Fool Staff - Motley Fool - Fri Nov 21, 9:27AM CST
Short-sellers have been piling into a number of healthcare stocks lately. This trend lends itself well to the possibility of exploiting a so-called "short squeeze", where share prices rise as short-sellers scramble to cover their positions. We asked...
JNJ: 104.59 (+0.31), INSY: 41.52 (+0.51), GERN: 3.06 (+0.05), RMTI: 8.41 (-0.07)
Critical Alerts For Nuverra Environmental Solutions, Marvell Technology, Pharmacyclics, Aeropostale and Rockwell Medical Released By InvestorsObserver
PR Newswire - Fri Nov 21, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for NES, MRVL, PCYC, ARO and RMTI.
NES: 4.96 (-0.44), PCYC: 121.84 (+1.15), MRVL: 14.33 (+0.01), RMTI: 8.41 (-0.07), ARO: 2.30 (-0.03)
Nasdaq stocks posting largest percentage decreases
AP - Thu Nov 20, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
IMDZ: 34.96 (+0.78), ANY: 5.99 (+0.36), SNCR: 43.24 (+0.21), CLVS: 54.58 (+0.43), CYAN: 7.00 (+0.50), RTRX: 12.92 (+0.19), RAVN: 25.52 (-0.07), RMTI: 8.41 (-0.07), DWCH: 9.08 (-0.07)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 11:46AM CST
NETE: 1.20 (unch), ANV: 0.88 (+0.02), LXRX: 0.90 (+0.02), CYAN: 7.00 (+0.50), JMEI: 15.09 (+0.21), LQDT: 8.19 (-0.19), KIRK: 23.38 (+0.14), IMNP: 1.89 (+0.02), RMTI: 8.41 (-0.07), FES: 1.19 (-0.01), DWCH: 9.08 (-0.07), AMDA: 0.64 (-0.01), CYBX: 54.63 (+0.48), BAMM: 1.70 (-0.04), CRMT: 51.59 (-0.12), EDAP: 1.97 (+0.01), BPTH: 2.80 (+0.03), MAGS: 5.48 (+0.29), RITT: 0.94 (-0.02), ENG: 1.80 (unch)
Rockwell prices offering
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 9:39AM CST
RMTI: 8.41 (-0.07)
Rockwell Medical (RMTI) Stock Falls After Company Prices Public Offering
at The Street - Thu Nov 20, 9:00AM CST
Shares of Rockwell Medical (RMTI) were down in morning trading Thursday after the company priced a public offering of common stock.
RMTI: 8.41 (-0.07)
Rockwell Medical Prices $58.5 Million Public Offering of Common Stock
GlobeNewswire - Thu Nov 20, 12:20AM CST
Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis, announced today that it has priced an underwritten public offering of 6,500,000 shares of its common stock at a price to the public of $9.00 per share for gross proceeds of $58.5 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Rockwell, will be approximately $54.7 million. Rockwell has also granted the underwriters a 30-day option to purchase up to an additional 975,000 shares of common stock offered in the public offering.
RMTI: 8.41 (-0.07)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 4:40PM CST
URBN: 34.15 (-0.53), DHX: 10.28 (+0.08), ACT: 254.20 (-1.68), OME: 10.00 (+0.09), CLVS: 54.58 (+0.43), AVB: 166.95 (-1.27), PF: 35.32 (+0.13), RMTI: 8.41 (-0.07), GLW: 23.22 (+0.08), FOLD: 7.94 (+0.06)
One Factor Driving Rockwell Medical (RMTI) Stock Down in After-Hours Trading Today
at The Street - Mon Nov 17, 3:47PM CST
Rockwell Medical (RMTI) shares are lower after the company announced its intention for a $55 million public offering of common stock.
RMTI: 8.41 (-0.07)
Rockwell Medical Announces $55 Million Proposed Public Offering of Common Stock
GlobeNewswire - Mon Nov 17, 3:15PM CST
Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis, announced today its intention to offer up to $55 million of its common shares in an underwritten public offering. Rockwell also expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering.
RMTI: 8.41 (-0.07)
Earnings Look Back: Rockwell Medical Technologies Is Down 3.5% Since Reporting Quarterly Results 1 Week Ago (RMTI)
Comtex SmarTrend(R) - Mon Nov 17, 1:14PM CST
A week ago on November 10th, 2014 Rockwell Medical Technologies (NASDAQ:RMTI) reported earnings and analysts, on average, expected a loss of $0.10 on sales of $13.6 million. Rockwell Medical Technologies actually reported a loss of $0.10 per share on sales of $13.7 million, missing EPS estimates by $0.00 and matching revenue estimates. Since the company's report, shares of Rockwell Medical Technologies have fallen from $10.90 to $10.52, representing a loss of 3.5% in the past 7 days.
RMTI: 8.41 (-0.07)